Thanks Kay. Excellent news! The IP protection continues to roll forward. I've thought for some time that AZN have had unofficial discussion with Amarin in the range somewhere between 22-28 bucks. We just need an NCE decision and we move forward.
With the commercial launch happening on Monday, I still am dumbfounded that so little has been reported or can be found on the net. I haven't heard from any cardiologist who have been approached by a AMRN rep either. Just seems weird.
Sentiment: Strong Buy